Target intelligence / Profile preview

Microorganism (including virus and bacterium)

Molecular classification
Other
01

Overview

"Microorganisms including viruses and bacteria" is a broad, non-canonical category encompassing diverse infectious agents that can cause disease in humans and other hosts. They are frequent targets of therapeutic intervention through broad- or narrow-spectrum antibiotics, antivirals, and other anti-infective agents. However, because this term refers to groups rather than specific molecules or biological entities, it cannot be classified as a single therapeutic target. Modern drug development increasingly emphasizes narrow-spectrum or targeted approaches (e.g., species- or strain-specific) to avoid collateral damage to the beneficial microbiome and limit resistance[1][2]. Additionally, microbial biofilms and metabolic pathways can be targeted for more efficient and selective therapies, but each approach still focuses on specific, well-defined molecular targets within individual microbes[4][1]. This entry is too broad for molecular target databases, where each entry should ideally represent a unique, well-defined biological molecule or structure.

Other names
MicroorganismsMicrobesPathogensVirus and bacteriumMicrobial organisms
02

Mechanism of action

Inhibition of cell wall or membrane synthesis (antibiotics targeting bacteria); Inhibition of metabolic enzymes/proteins (e.g., bacterial or viral enzymes targeted by drugs); Inhibition of nucleic acid replication (many antivirals/bactericidals); Disruption of biofilm matrix or signaling (biofilm-targeting therapies); Immune modulation or enhancement (some biologics, vaccines).

03

Biological functions

InfectionPathogenesisBiofilm formation (for some bacteria)Immune evasionMetabolic activity
04

Disease associations

InfectionCancer (some viruses, e.g., HPV, EBV)InflammationCardiovascular diseases (via dysbiosis or infection)Neurodegenerative disease (via microbiome interactions or infectious agents)
05

Safety considerations

Broad-spectrum disruption of host microbiome (antibiotics)Drug resistance (antibiotic, antiviral resistance)Off-target effects or toxicity (e.g., cytotoxicity of some biofilm disruptors like nitric oxide)Difficulty selectively targeting pathogens without harming beneficial microbiota
06

Interacting drugs

Antibiotics (penicillins, cephalosporins, aminoglycosides, etc.—target bacteria)

5 more in the full profile.

07

Biomarkers

Pathogen DNA/RNA (PCR tests)Antigen presence (rapid tests, ELISA)Immune response signatures (antibody titers, cytokine levels)Microbial metabolite profiles

Beyond the preview

Go deeper on Microorganism (including virus and bacterium).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microorganism (including virus and bacterium).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call